U.S. Pharmaceutical Sales - Q4 2011
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q4 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q4 2011 by sales
- Sales Statistics Q4 2011
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Lipitor
|
1,601,663 |
-18.69% |
Stats |
2 |
Plavix
|
1,575,841 |
-3.38% |
Stats |
3 |
Nexium AstraZeneca |
1,440,333 |
-0.10% |
Stats |
4 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,283,021 |
2.66% |
Stats |
5 |
Singulair Merck |
1,139,301 |
2.59% |
Stats |
6 |
Seroquel AstraZeneca |
1,124,163 |
1.71% |
Stats |
7 |
Advair Diskus GlaxoSmithKline |
1,121,157 |
5.66% |
Stats |
8 |
Crestor AstraZeneca |
1,092,260 |
3.69% |
Stats |
9 |
Cymbalta
|
956,723 |
4.70% |
Stats |
10 ( 1) |
Humira AbbVie Inc. |
905,527 |
3.18% |
Stats |
11 ( 1) |
Enbrel Amgen Inc. |
873,343 |
1.67% |
Stats |
12 ( 2) |
Neulasta Amgen Inc. |
822,578 |
4.59% |
Stats |
13 ( 3) |
Remicade Janssen Pharmaceuticals, Inc. |
817,365 |
-7.02% |
Stats |
14 ( 2) |
Rituxan Genentech, Inc. |
771,622 |
6.96% |
Stats |
15 ( 3) |
Lexapro Allergan plc |
718,613 |
3.12% |
Stats |
16 ( 1) |
Copaxone Teva Pharmaceuticals USA, Inc. |
715,745 |
0.98% |
Stats |
17 ( 2) |
OxyContin Purdue Pharma LP |
669,915 |
-2.58% |
Stats |
18 ( 3) |
Actos Takeda Pharmaceutical Company Limited |
660,834 |
-15.22% |
Stats |
19 ( 1) |
Atripla Gilead Sciences, Inc. |
657,962 |
4.92% |
Stats |
20 ( 2) |
Epogen Amgen Inc. |
648,794 |
4.67% |
Stats |
21 |
Avastin Genentech, Inc. |
644,570 |
2.86% |
Stats |
22 ( 1) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
610,265 |
6.93% |
Stats |
23 ( 1) |
Januvia Merck |
540,947 |
4.87% |
Stats |
24 ( ) |
atorvastatin Generic |
505,092 |
n/a |
Stats |
25 |
Truvada Gilead Sciences, Inc. |
504,186 |
3.43% |
Stats |
26 ( 12) |
enoxaparin Generic |
482,286 |
36.13% |
Stats |
27 ( 1) |
Lantus Sanofi |
474,189 |
0.69% |
Stats |
28 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
453,233 |
0.69% |
Stats |
29 ( 11) |
Incivek Vertex Pharmaceuticals Incorporated |
446,754 |
33.13% |
Stats |
30 ( 2) |
Lucentis Genentech, Inc. |
439,867 |
2.44% |
Stats |
31 ( 2) |
Lyrica
|
432,070 |
1.23% |
Stats |
32 ( 2) |
Celebrex
|
426,391 |
1.12% |
Stats |
33 ( 2) |
Herceptin Genentech, Inc. |
425,931 |
7.61% |
Stats |
34 |
Lantus Solostar Sanofi |
408,336 |
8.54% |
Stats |
35 ( 4) |
Eloxatin Sanofi |
398,541 |
12.60% |
Stats |
36 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
390,547 |
4.38% |
Stats |
37 ( 1) |
Namenda Allergan plc |
381,310 |
6.06% |
Stats |
38 ( 5) |
Avonex Biogen |
380,189 |
0.19% |
Stats |
39 ( ) |
olanzapine Generic |
379,423 |
n/a |
Stats |
40 ( 8) |
Diovan HCT Novartis Pharmaceuticals Corporation |
379,367 |
-1.99% |
Stats |
41 ( 28) |
Zyprexa
|
379,000 |
-54.28% |
Stats |
42 ( 5) |
OneTouch
|
361,509 |
0.66% |
Stats |
43 ( 2) |
Vyvanse Takeda Pharmaceutical Company Limited |
348,645 |
13.05% |
Stats |
44 ( 1) |
Suboxone
|
331,741 |
6.35% |
Stats |
45 ( 4) |
Geodon
|
330,022 |
-1.27% |
Stats |
46 ( 2) |
Zetia Merck |
320,115 |
2.80% |
Stats |
47 |
Provigil
|
312,978 |
9.48% |
Stats |
48 ( 6) |
TriCor AbbVie Inc. |
312,497 |
-2.67% |
Stats |
49 ( 3) |
Lidoderm Endo Pharmaceuticals Inc. |
308,945 |
7.01% |
Stats |
50 ( 2) |
methylphenidate Generic |
303,055 |
16.12% |
Stats |
51 ( ) |
Synagis MedImmune, Inc. |
286,731 |
n/a |
Stats |
52 ( 4) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
282,423 |
10.49% |
Stats |
53 ( 3) |
AndroGel AbbVie Inc. |
280,432 |
5.44% |
Stats |
54 ( 3) |
amphetamine/dextroamphetamine Generic |
278,276 |
9.03% |
Stats |
55 ( 2) |
Procrit Janssen Pharmaceuticals, Inc. |
269,937 |
3.58% |
Stats |
56 ( 8) |
Symbicort AstraZeneca |
267,373 |
11.05% |
Stats |
57 ( 28) |
budesonide Generic |
266,769 |
51.97% |
Stats |
58 ( 9) |
Niaspan AbbVie Inc. |
264,055 |
-1.11% |
Stats |
59 ( 4) |
Seroquel XR AstraZeneca |
261,947 |
2.27% |
Stats |
60 ( 2) |
Alimta Eli Lilly and Company |
259,810 |
1.82% |
Stats |
61 ( 7) |
Rebif EMD Serono, Inc. |
258,643 |
0.43% |
Stats |
62 ( 3) |
Viagra
|
257,541 |
1.74% |
Stats |
63 ( 3) |
Novolog Novo Nordisk |
252,015 |
0.97% |
Stats |
64 ( 4) |
Nasonex Merck |
251,582 |
9.30% |
Stats |
65 ( 2) |
Humalog Eli Lilly and Company |
251,367 |
3.78% |
Stats |
66 ( 15) |
Aranesp Amgen Inc. |
246,056 |
-6.07% |
Stats |
67 ( 5) |
Flovent HFA GlaxoSmithKline |
245,114 |
15.06% |
Stats |
68 ( 1) |
Lovaza GlaxoSmithKline |
244,272 |
5.34% |
Stats |
69 ( 3) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
241,059 |
1.93% |
Stats |
70 ( 5) |
Neupogen Amgen Inc. |
238,289 |
0.16% |
Stats |
71 ( 10) |
Vytorin Merck |
235,267 |
-3.61% |
Stats |
72 ( 2) |
Reyataz Bristol-Myers Squibb Company |
234,758 |
3.45% |
Stats |
73 ( 4) |
metoprolol Generic |
232,625 |
1.20% |
Stats |
74 ( 3) |
Adderall XR Takeda Pharmaceutical Company Limited |
225,825 |
2.80% |
Stats |
75 ( 1) |
Levemir Novo Nordisk |
219,295 |
8.66% |
Stats |
76 ( 4) |
NovoLog FlexPen Novo Nordisk |
208,552 |
10.19% |
Stats |
77 ( 2) |
Aciphex Eisai Inc. |
206,760 |
-1.37% |
Stats |
78 |
Isentress Merck |
206,451 |
6.07% |
Stats |
79 ( 5) |
fentanyl Generic |
204,161 |
-2.90% |
Stats |
80 ( 1) |
Cialis Eli Lilly and Company |
200,494 |
4.24% |
Stats |
81 ( 19) |
Lovenox Sanofi |
197,102 |
-19.10% |
Stats |
82 ( 1) |
Lunesta Sunovion Pharmaceuticals Inc. |
196,388 |
4.17% |
Stats |
83 ( 1) |
Janumet Merck |
195,470 |
3.95% |
Stats |
84 ( 11) |
Solodyn Medicis Pharmaceutical Corporation |
194,898 |
-7.87% |
Stats |
85 ( 7) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
191,260 |
16.27% |
Stats |
86 |
Restasis Allergan plc |
190,745 |
8.79% |
Stats |
87 ( 9) |
acetaminophen/hydrocodone Generic |
185,206 |
16.09% |
Stats |
88 ( 11) |
Prevnar 13 Pfizer Inc. |
181,189 |
-6.93% |
Stats |
89 |
Velcade Takeda Pharmaceutical Company Limited |
180,600 |
5.82% |
Stats |
90 ( 42) |
Varivax Merck |
175,987 |
-36.43% |
Stats |
91 ( ) |
Pegasys Genentech, Inc. |
174,833 |
n/a |
Stats |
92 ( 2) |
Opana ER Endo Pharmaceuticals Inc. |
173,371 |
7.28% |
Stats |
93 ( 5) |
Zyvox Pfizer Inc. |
172,862 |
1.17% |
Stats |
94 ( 1) |
Benicar Daiichi Sankyo |
169,877 |
4.87% |
Stats |
95 ( 11) |
Evista
|
168,353 |
-4.69% |
Stats |
96 ( 5) |
Xeloda Genentech, Inc. |
168,186 |
1.39% |
Stats |
97 ( 7) |
Erbitux Eli Lilly and Company |
167,657 |
-0.15% |
Stats |
98 ( 2) |
Prezista Janssen Pharmaceuticals, Inc. |
167,454 |
7.73% |
Stats |
99 ( 12) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
167,236 |
-3.76% |
Stats |
100 ( 1) |
VESIcare Astellas Pharma US, Inc. |
163,751 |
4.12% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.